Atorvastatin in Patients With Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Atorvastatin 80mg

Atorvastatin is one of the most effective drugs used to reduce intracellular cholesterol synthesis. it exerts numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement, and immunomodulation independent of its basic lipid-lowering properties

Trial Locations (1)

35511

Faculty of Medicine, Mansoura University, Al Mansurah

All Listed Sponsors
lead

Tanta University

OTHER